))
Unmet Needs in EGFR+ mNSCLC
Manage episode 439458500 series 3599769
Innehåll tillhandahållet av OntadaLearn. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av OntadaLearn eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Welcome to episode one of three, where we dive deep into the challenges and advancements in managing locally Advanced or Metastatic EGFR+ Non-Small-Cell Lung Cancer (NSCLC). This educational opportunity is brought to you by Johnson & Johnson.
Join Dr. Mark Socinski, Executive Medical Director of the Advent Health Cancer Institute, and Dr. Dave Waterhouse from Oncology Hematology Care in Cincinnati, Ohio, as they discuss the importance of biomarker testing, the evolution of treatment strategies, and the impact of effective first-line therapies on patient outcomes.
3 episoder
Dela
